Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb

October 30, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 30 /- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced the ANA598 data to be presented at the 61st Annual Meeting of the American Association for the Study of Liver Disease (AASLD) in Boston, MA.  ANA598, the Company's direct-acting antiviral (DAA) being...

TOPICS:

Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Int...

October 30, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

BOSTON and RIDGEFIELD, Conn., Oct. 30, 2010 /- Boehringer Ingelheim Pharmaceuticals, Inc. announced today results from a Phase Ib study, SOUND-C1, that showed the combination of two oral hepatitis C virus (HCV) compounds, the protease inhibitor BI 201335 and the polymerase inhibitor BI...

TOPICS:

Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes

October 30, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

BOSTON, Oct. 30 /- Researchers from the University of Bari, Italy, concluded that treating patients after transplantation with antiviral therapy creates a sustained viral response (SVR) and protects them from liver-related deaths. The purpose of this study was to determine the long-term...

TOPICS:
Advertisement

Surrogate decision makers wish to retain authority in difficult decision

October 29, 2010 4:35 pm | by EurekAlert | News | Comments

(American Thoracic Society) The decision to stop life-support for incapacitated and critically ill patients is, for surrogate decision makers, often fraught with moral and ethical uncertainty, and long-term emotional consequences. But as difficult as these decisions are, more than half of...

TOPICS:

Allergy Update: Know your treatment options

October 29, 2010 4:34 pm | by Baylor College of Medicine | News | Comments

Allergies got you down? Dr. Madhu Narra , assistant professor of medicine in the section of allergy, immunology and rheumatology at Baylor College of Medicine discusses potential treatment options. Classic allergy symptoms include runny and itchy eyes and nose, sneezing, congestion,...

TOPICS:

Stryker acquires Porex Surgical

October 29, 2010 2:45 pm | by The Associated Press | News | Comments

Medical technology company Stryker Corp. is acquiring privately held Porex Surgical, a medical products company and division of Porex Corp.The terms of the deal were not disclosed.Stryker, which announced the deal Friday, said Porex's products — used primarily in reconstructive surgery of the...

PerkinElmer teams with LinaTech in radiotherapy

October 29, 2010 1:45 pm | by The Associated Press | News | Comments

Medical instrument maker PerkinElmer Inc. said Friday that it agreed to jointly develop and sell a radiotherapy technology with device maker LinaTech.Among the products is a cost-effective imaging solution that allows customers to upgrade their film-based radiotherapy systems, it said.The first...

Slip Into The Secret Life of Eels

October 29, 2010 1:38 pm | Podcasts | Comments

In his new book Eels, writer James Prosek describes the life history and cultural significance of this slimy, snake-like and often misunderstood fish, introducing the reader to an eel fisherman on the Delaware River and to the myths of the Maori of New Zealand along the way.

Advertisement

Taste Receptors In Lungs May Help Asthmatics

October 29, 2010 1:37 pm | Podcasts | Comments

Writing in Nature Medicine, researchers report on discovering bitter taste receptors in human lungs, and that bitter compounds expand airways in asthmatic mice. Stephen Liggett talks about the possibility of treating asthma and chronic obstructive pulmonary disease with bitter compounds.

Is Genome Sequencing Surpassing Medical Knowledge?

October 29, 2010 1:37 pm | Podcasts | Comments

The cost of sequencing a human genome is plummeting, and soon many people may obtain a copy of their own. But how useful is that information to patients, especially if their genes predict untreatable, fatal diseases? Hank Greely discusses the promise and the pitfalls of genetic testing.

The Mysterious Life Of The Cholera Bacterium

October 29, 2010 1:37 pm | Podcasts | Comments

Scientists have long known that cholera is caused by a bacterium transmitted through food or water. But where does the bacterium live between epidemics, and what dictates the timing of new outbreaks? CDC cholera expert Eric Mintz discusses the bacterium behind the Haiti outbreak.

'Goat Sucker' May Just Be A Mangy Coyote

October 29, 2010 1:37 pm | Podcasts | Comments

The legend of the ferocious chupacabra, or goat sucker, has circulated around Central America since the 1990s. But the supernatural chimeric beast -- described by some as half dog, half bat -- may just be a coyote suffering from mange, says entomologist Barry OConnor of the University of Michigan.

The Past, Locked In Amber

October 29, 2010 1:37 pm | Podcasts | Comments

Scientists excavating an Indian amber deposit say it dates back more than 50 million years, and contains the remains of at least 100 previously undocumented species of insects. American Museum of Natural History curator David Grimaldi describes the amber, and the organisms trapped within it.

Zebrafish yield clues to how we process visual information

October 29, 2010 1:35 pm | by Lawrence Berkeley National Laboratory | News | Comments

To a hungry fish on the prowl, the split-second neural processing required to see and gobble up prey is a matter of survival. To scientists, it’s a window into how our brain coordinates eye motions that enable us make our way in a world full of danger and opportunity. This process is now...

TOPICS:

Heparin Sodium (B. Braun): Recall - Trace Contaminant

October 29, 2010 1:31 pm | by U.S. Food & Drug Administration | News | Comments

Oversulfated chondroitin sulfate (OSCS) contaminant found during sample testing.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading